Sign In
Buy AXNX
$70.98
+0 (+0%)
At Close: Feb 13, 2025
BRIEF-Axonics Says U.S. FDA Approves Implantable Neurostimulator
11:02am, Tuesday, 14'th Apr 2020
Axonics Modulation Technologies Inc :
Axonics® Announces U.S. Food & Drug Administration Approval of Next Generation Implantable Neurostimulator
10:00am, Tuesday, 14'th Apr 2020
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation ("SNM") devices for the treatment
